SCHEMBL2921682

SCHEMBL2921682

CC(=O)Nc1c(C)cccc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.58
PDK2 Q15119 1/20 0.58
PDK3 Q15120 1/20 0.58
PDK4 Q16654 1/20 0.58
GAA P10253 1/20 0.57
ALDH1A1 P00352 2/20 0.50
HPGD P15428 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
MAOB P27338 1/20 0.48
CHRNA7 P36544 1/20 0.48
CXCL8 P10145 1/20 0.48
PTGS2 P35354 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.47
MAPK14 Q16539 4/20 0.47
S1PR2 O95136 1/20 0.47
S1PR4 O95977 1/20 0.47
LCK P06239 4/20 0.46
MAPK13 O15264 1/20 0.46
EGFR P00533 1/20 0.46
FYN P06241 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1272335 0.88 PDK1 (0.53) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL11402399 0.86 PDK1 (0.59) PDK1PDK2PDK3PDK4GAA
Hydrochloric Acid SCHEMBL5297660 0.86 PDK1 (0.51) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL436967 0.86 ALDH1A1 (0.59) GAAALDH1A1HPGDL3MBTL1
SCHEMBL9168588 0.84 ALDH1A1 (0.57) GAAALDH1A1HPGDL3MBTL1
SCHEMBL11735899 0.83 PDK1 (0.56) PDK1PDK2PDK3PDK4GAA
SCHEMBL8682011 0.83 GAA (0.60) PDK1PDK2PDK3PDK4GAA
SCHEMBL10691487 0.82 PDK1 (0.52) PDK1PDK2PDK3PDK4GAA
SCHEMBL14134668 0.81 PDK1 (0.51) PDK1PDK2PDK3PDK4GAA
SCHEMBL3785379 0.81 ALDH1A1 (0.50) GAAALDH1A1HPGDCXCL8SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4096333-A NITROSATION OF A 2-METHYLACETANILIDE TENNECO CHEMICALS, INC. (US) 1978-06-20 US claimed
US-3988347-A NITROSATION OF A 2-METHYL-ACETANILIDE WITH SODIUM NITRITE TENNECO CHEMICALS, INC. (US) 1976-10-26 US claimed
US-9249145-B2 Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors INCYTE HOLDINGS CORPORATION (US) 2016-02-02 US disclosed
US-8748432-B2 Microbiocidal pyrazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2014-06-10 US disclosed
US-8748432-B2 Microbiocidal pyrazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2014-06-10 US disclosed
US-8080669-B2 Process for the synthesis of 2-aminoxazole compounds AB SCIENCE (FR) 2011-12-20 US disclosed
US-20110059951-A1 HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS INCYTE CORPORATION 2011-03-10 US disclosed
EP-2019822-B1 A NEW PROCESS FOR THE SYNTHESIS OF 2-AMINOXAZOLE COMPOUNDS AB SCIENCE (FR) 2010-09-08 EP disclosed
US-20090192317-A1 PROCESS FOR THE SYNTHESIS OF 2-AMINOXAZOLE COMPOUNDS AB SCIENCE (FR) 2009-07-30 US disclosed
US-4612395-A Process for the production of N-(2-methyl-4-chlorophenyl)-formamidine derivatives CIBA-GEIGY CORPORATION (US) 1986-09-16 US disclosed
EP-0188502-A1 ETHERIFIED 2-HYDROXY-ETHYL-PHOSPHONIC ACID DERIVATIVES AND PLANT GROWTH REGULATING AGENTS CONTAINING SAME AS ACTIVE INGREDIENT. NITROKEMIA IPARTELEPEK (HU) 1986-07-30 EP disclosed
EP-0187806-A1 2-CHLORO-ETHYL PHOSPHONIC ACID ESTERS AND PLANT GROWTH REGULATING AGENTS CONTAINING SAME AS ACTIVE INGREDIENT NITROKEMIA IPARTELEPEK (HU) 1986-07-23 EP disclosed
US-4600797-A NITRATING AN AMINOBENZENE WHICH HAS A PROTECTEDD AMINO GROUP BAYER AKTIENGESELLSCHAFT (DE) 1986-07-15 US disclosed
WO-1986000904-A1 ETHERIFIED 2-HYDROXY-ETHYL-PHOSPHONIC ACID DERIVATIVES AND PLANT GROWTH REGULATING AGENTS CONTAINING SAME AS ACTIVE INGREDIENT NITROKÉMIA IPARTELEPEK (HU) 1986-02-13 WO disclosed
WO-1986000903-A1 2-CHLORO-ETHYL PHOSPHONIC ACID ESTERS AND PLANT GROWTH REGULATING AGENTS CONTAINING SAME AS ACTIVE INGREDIENT NITROKÉMIA IPARTELEPEK (HU) 1986-02-13 WO disclosed
EP-0049711-B1 PROCESS FOR THE PRODUCTION OF NITRO-AMINO-BENZENES BAYER AG (DE) 1984-02-29 EP disclosed
EP-0049711-A1 Process for the production of nitro-amino-benzenes BAYER AG (DE) 1982-04-21 EP disclosed
US-4160017-A EMETIC AGENTS IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1979-07-03 US disclosed
US-4102924-A REACTING ACYLAMINO-ARYLS WITH HALO-ARYLS BAYER AKTIENGESELLSCHAFT (DE) 1978-07-25 US disclosed
US-4096333-A NITROSATION OF A 2-METHYLACETANILIDE TENNECO CHEMICALS, INC. (US) 1978-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059951-A1 HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS JAK3, JAK1, JAK2 PDK1 251/4885PDK2 184/4885PDK3 255/4885
US-20090192317-A1 PROCESS FOR THE SYNTHESIS OF 2-AMINOXAZOLE COMPOUNDS ABL1, FLT3, ABL2 PDK1 1216/4885PDK2 863/4885PDK3 1088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.